Medicine for treating breast cancer and its preparation method and application
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A breast cancer and drug technology, applied in the field of medicine, can solve problems such as leukopenia, high recurrence risk, etc., and achieve the effects of high curative effect, no toxic side effects, and simple preparation process
Inactive Publication Date: 2017-06-16
ZHENGZHOU RENHONG PHARMA CO LTD
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, studies have shown that breast cancer patients still face a higher risk of recurrence after the initial surgery, and the peak of recurrence is concentrated at about 2 years
Postoperative chemotherapy and endocrine therapy can reduce the annual mortality rate of breast cancer by about 20%, but chemotherapy, radiotherapy, and endocrine therapy often produce gastrointestinal reactions, leukopenia, hair loss and other side effects
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0018] In the embodiment of the present invention, a medicine for treating breast cancer is composed of the following raw materials in parts by weight: 3 parts of sesamol, 7 parts of diclofenac sodium, 1 part of niacin, and 11 parts of inositol.
[0019] Mix sesamol, diclofenac sodium and inositol, add deionized water with 3.8 times the mass of the three, microwave for 8 minutes, and microwave power is 800W to prepare mixture A. Mix the mixture A and niacin, ultrasonically process for 20min at a temperature of 40°C, the ultrasonic power is 600W, and then stir at 45°C until dry to obtain a medicine.
Embodiment 2
[0021] In the embodiment of the present invention, a medicine for treating breast cancer is composed of the following raw materials in parts by weight: 7 parts of sesamol, 15 parts of diclofenac sodium, 3 parts of niacin, and 19 parts of inositol.
[0022] Mix sesamol, diclofenac sodium and inositol, add deionized water with 3.8 times the mass of the three, microwave for 8 minutes, and microwave power is 800W to prepare mixture A. Mix the mixture A and niacin, ultrasonically process for 20min at a temperature of 40°C, the ultrasonic power is 600W, and then stir at 45°C until dry to obtain a medicine.
Embodiment 3
[0024] In the embodiment of the present invention, a medicine for treating breast cancer is composed of the following raw materials in parts by weight: 4 parts of sesamol, 9 parts of diclofenac sodium, 1.5 parts of niacin, and 13 parts of inositol.
[0025] Mix sesamol, diclofenac sodium and inositol, add deionized water with 3.8 times the mass of the three, microwave for 8 minutes, and microwave power is 800W to prepare mixture A. Mix the mixture A and niacin, ultrasonically process for 20min at a temperature of 40°C, the ultrasonic power is 600W, and then stir at 45°C until dry to obtain a medicine.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a medicine for treating breast cancer and its preparation method and application. The medicine is composed of 3 to 7 parts by weight of sesamol, 7 to 15 parts of diclofenac sodium, 1 to 3 parts of niacin and 11 to 19 parts of inositol. The preparation method comprises mixing sesamol, diclofenac sodium and inositol, adding deionized water of which the mass is 3.8 times that of the mixture into the mixture, carrying out microwave treatment for 8min to obtain a mixture A, mixing the mixture A and niacin, carrying out ultrasonic treatment at a temperature of 40 DEG C for 20min, and carrying out stirring at a temperature of 45 DEG C until a dry medicine is obtained. Through synergism of all the raw materials, the medicine has obvious effects of resisting breast cancer, has low toxic or side effects and has unexpected technical effects. The medicine has the advantages of simple and easily available raw materials, small dosage, high curative effect and no toxic or side effect. The medicine can be used as a breast cancer-resistant drug, can be prepared by simple processes, realizes a low cost and is suitable for large-scale promotion.
Description
technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating breast cancer and a preparation method and application thereof. Background technique [0002] Cancer is a common and frequently-occurring disease that seriously endangers people's lives and health. Due to the different parts of cancer, there can be various types of cancers, such as breast cancer, stomach cancer, breast cancer, bone cancer, skin cancer, bowel cancer, and liver cancer. and many more. [0003] Breast cancer is a malignant tumor that occurs in the glandular epithelium of the breast. 99% of breast cancers occur in women and only 1% in men. The etiology of breast cancer is not yet fully understood. Studies have found that there is a certain regularity in the incidence of breast cancer. Women with high risk factors for breast cancer are prone to breast cancer. The so-called high-risk factors refer to various risk factors related to the incide...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more